BACKGROUND: Germline genetic susceptibilities of rare cancers of the esophagus, stomach, small intestine, testis, (nonmedullary) thyroid gland and bone with high familial risks are not well known. Here, we use familial risk data from the Swedish Family-Cancer Database which contains records of cancers in Swedish families obtained over a century. We compare familial risks for offspring diagnosed with any of these cancers when their parent had or had not that cancer. We review the global literature of the reported constitutional variants that may explain part of the familial risk. MAIN BODY: Familial risks for esophageal and stomach cancers are about 2.0 and apart from early-onset stomach cancer few high-risk variants are known. Genetic studies may be hampered by dominant environmental risk factors for these cancers. Small intestinal carcinoids have a very high familial risk (28 between siblings) but no high-risk genes have been identified to explain this. Low-risk polygenic variants have been identified. Small intestinal adenocarcinoma is a manifestation in Lynch syndrome. Testicular and thyroid cancers are characterized by high familial risk (about 5) which may be explained largely by a polygenic background, although thyroid cancer is a component in a number of rare cancer syndromes. Several predisposing genes have been identified for bone cancer (familial risk 7). CONCLUSIONS: The discussed cancers are rare and they present with a relatively high familial risk, in spite of lacking identified high-penetrant constitutional variants. It is possible that the polygenic component, already recognized for testis cancer, is stronger than previously expected. Thus polygenic models with rare high/moderate- and low-risk variants could fit the familial risk and shape the germline genetic landscape of these cancers. Polygenic background may have clinical implications.

Biomedical Center Faculty of Medicine Charles University Pilsen 30605 Czech Republic

Cancer Gene Therapy Group Translational Immunology Research Program University of Helsinki Helsinki Finland

Comprehensive Cancer Center Helsinki University Hospital Helsinki Finland

Department of Otorhinolaryngology Head and Neck Surgery Helsinki University Hospital and University of Helsinki Helsinki Finland

Department of Urology Helsinki University Hospital Helsinki Finland

Division of Cancer Epidemiology German Cancer Research Center Im Neuenheimer Feld 580 D 69120 Heidelberg Germany

Division of Pediatric Neurooncology German Cancer Research Center Heidelberg Germany

Hopp Children's Cancer Center Heidelberg Germany

Skin and Allergy Hospital Helsinki University Hospital and University of Helsinki Helsinki Finland

Zobrazit více v PubMed

Walsh T, King MC. Ten genes for inherited breast cancer. Cancer Cell. 2007;11(2):103–5. PubMed

Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–32. PubMed

Hemminki K, Sundquist K, Sundquist J, Försti A, Hemminki A, Li X. Familial risks and proportions describing Population Landscape of Familial Cancer. Cancers. 2021;13:17. PubMed PMC

Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS. Chromosome 15q25 (CHRNA3-CHRNA5) variation impacts indirectly on lung cancer risk. PLoS ONE. 2011;6(4):e19085. PubMed PMC

Zou K, Sun P, Huang H, Zhuo H, Qie R, Xie Y, et al. Etiology of lung cancer: evidence from epidemiologic studies. J Natl Cancer Cent. 2022;2(4):216–25. PubMed PMC

Zur Hausen H. The search for infectious causes of human cancers: where and why. Virology. 2009;392:1–10. PubMed

Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, et al. Breast Cancer Risk Genes - Association Analysis in more than 113,000 women. N Engl J Med. 2021;384(5):428–39. PubMed PMC

Hassanin E, May P, Aldisi R, Spier I, Forstner AJ, Nöthen MM, et al. Breast and prostate cancer risk: the interplay of polygenic risk, rare pathogenic germline variants, and family history. Genet Med. 2022;24(3):576–85. PubMed

Kang JH, Lee Y, Kim DJ, Kim JW, Cheon MJ, Lee BC. Polygenic risk and rare variant gene clustering enhance cancer risk stratification for breast and prostate cancers. Commun Biology. 2024;7(1):1289. PubMed PMC

Hemminki K, Ji J, Brandt A, Mousavi SM, Sundquist J. The Swedish Family-Cancer database 2009: prospects for histology-specific and immigrant studies. Int J Cancer. 2010;126:2259–67. PubMed

Ji J, Sundquist K, Sundquist J, Hemminki K. Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry. Int J Cancer. 2012;131:2085–93. PubMed

Sud A, Kinnersley B, Houlston RS. Genome-wide association studies of cancer: current insights and future perspectives. Nat Rev Cancer. 2017;17(11):692–704. PubMed

Jeremiasen M, Linder G, Hedberg J, Lundell L, Björ O, Lindblad M et al. Improvements in esophageal and gastric cancer care in Sweden-population-based results 2007–2016 from a national quality register. Dis Esophagus. 2020;33(3). PubMed PMC

Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin. 2013;63(4):232–48. PubMed

Uson PLS Jr., Kunze KL, Golafshar MA, Botrus G, Riegert-Johnson D, Boardman L, et al. Germline Cancer testing in unselected patients with gastric and esophageal cancers: a multi-center prospective study. Dig Dis Sci. 2022;67(11):5107–15. PubMed PMC

Lee M, Eng G, Handte-Reinecker A, Deshpande VS, Yilmaz OH, Gala MK. Germline determinants of esophageal adenocarcinoma. Gastroenterology. 2023;165(5):1276–e97. PubMed PMC

Decourtye-Espiard L, Guilford P. Hereditary diffuse gastric Cancer. Gastroenterology. 2023;164(5):719–35. PubMed

Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–48. PubMed

Landerholm K. Time trends in incidence and survival of small intestinal cancer in Sweden. BJS Open. 2021;5(1). PubMed PMC

Kharazmi E, Pukkala E, Sundquist K, Hemminki K. Familial risk of small intestinal carcinoid and adenocarcinoma. Clin Gastroenterol Hepatol. 2013;11(8):944–9. PubMed

Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the prospective Lynch Syndrome Database. Genet Med. 2020;22(1):15–25. PubMed PMC

Sei Y, Zhao X, Forbes J, Szymczak S, Li Q, Trivedi A, et al. A Hereditary Form of Small Intestinal Carcinoid Associated with a germline mutation in Inositol Polyphosphate Multikinase. Gastroenterology. 2015;149(1):67–78. PubMed PMC

de Mestier L, Pasmant E, Fleury C, Brixi H, Sohier P, Féron T, et al. Familial small-intestine carcinoids: chromosomal alterations and germline inositol polyphosphate multikinase sequencing. Dig Liver Dis. 2017;49(1):98–102. PubMed

Dumanski JP, Rasi C, Björklund P, Davies H, Ali AS, Grönberg M, et al. A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors. Endocr Relat Cancer. 2017;24(8):427–43. PubMed PMC

Rapley EA, Turnbull C, Al Olama AA, Dermitzakis ET, Linger R, Huddart RA, et al. A genome-wide association study of testicular germ cell tumor. Nat Genet. 2009;41(7):807–10. PubMed PMC

Pluta J, Pyle LC, Nead KT, Wilf R, Li M, Mitra N, et al. Identification of 22 susceptibility loci associated with testicular germ cell tumors. Nat Commun. 2021;12(1):4487. PubMed PMC

Zhang YD, Hurson AN, Zhang H, Choudhury PP, Easton DF, Milne RL, et al. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nat Commun. 2020;11(1):3353. PubMed PMC

Loveday C, Law P, Litchfield K, Levy M, Holroyd A, Broderick P, et al. Large-scale analysis demonstrates familial testicular Cancer to have Polygenic Aetiology. Eur Urol. 2018;74(3):248–52. PubMed

Fallah M, Pukkala E, Tryggvadottir L, Olsen JH, Tretli S, Sundquist K, et al. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five nordic countries. J Med Genet. 2013;50(6):373–82. PubMed

Kamani T, Charkhchi P, Zahedi A, Akbari MR. Genetic susceptibility to hereditary non-medullary thyroid cancer. Hereditary cancer Clin Pract. 2022;20(1):9. PubMed PMC

Zitricky F, Koskinen A, Sundquist K, Sundquist J, Liska V, Försti A, et al. Survival in thyroid Cancer in Sweden from 1999 to 2018. Clin Epidemiol. 2024;16:659–71. PubMed PMC

González IA, Stewart DR, Schultz KAP, Field AP, Hill DA, Dehner LP. DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma. Mod Pathology: Official J United States Can Acad Pathol Inc. 2022;35(1):4–22. PubMed PMC

Tichanek F, Försti A, Hemminki O, Hemminki A, Hemminki K. Steady survival improvements in soft tissue and bone sarcoma in the nordic countries through 50 years. Cancer Epidemiol. 2023:102449. PubMed

Akhavanfard S, Padmanabhan R, Yehia L, Cheng F, Eng C. Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. Nat Commun. 2020;11(1):2206. PubMed PMC

Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal reflux disease: a review. JAMA. 2020;324(24):2536–47. PubMed

Hassanin E, Spier I, Bobbili DR, Aldisi R, Klinkhammer H, David F, et al. Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence. BMC Med Genom. 2023;16(1):42. PubMed PMC

Collister JA, Liu X, Littlejohns TJ, Cuzick J, Clifton L, Hunter DJ. Assessing the value of incorporating a polygenic risk score with nongenetic factors for Predicting breast Cancer diagnosis in the UK Biobank. Cancer Epidemiol Biomarkers Prev. 2024;33(6):812–20. PubMed PMC

Mars N, Kerminen S, Tamlander M, Pirinen M, Jakkula E, Aaltonen K, et al. Comprehensive inherited risk estimation for risk-based breast Cancer screening in women. J Clin Oncol. 2024;42(13):1477–87. PubMed PMC

Mars N, Lindbohm JV, Della Briotta Parolo P, Widén E, Kaprio J, Palotie A, et al. Systematic comparison of family history and polygenic risk across 24 common diseases. Am J Hum Genet. 2022;109(12):2152–62. PubMed PMC

Reid NJ, Brockman DG, Elisabeth Leonard C, Pelletier R, Khera AV. Concordance of a high polygenic score among relatives: implications for genetic Counseling and Cascade Screening. Circ Genom Precis Med. 2021;14(2):e003262. PubMed PMC